๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Loss of Chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers

โœ Scribed by Arthur R. Brothman; Michael R. Steele; Briana J. Williams; Emma Jones; Shannon Odelberg; Hans M. Albertsen; Lynn B. Jorde; L. Ralph Rohr; Robert A. Stephenson


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
619 KB
Volume
13
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

โœฆ Synopsis


Using a polymerase chain reaction/microsatellite marker system, we demonstrated that 6 of 22 (27%) clinical stage B (early) primary prostate tumors showed loss of heterozygosity at one or more of five loci on chromosome 17. The sensitivity of this study was increased by use of a Phosphorlmager and statistical analysis of replicate tumor-normal DNA pairs. Two patients showed tumor-specific interstitial loss at a locus in close proximity to the familial breast cancer gene BRCAI. These findings suggest that genes on the proximal long arm of chromosome I7 play a pivotal role in the early development of at least a subset of prostatic tumors. Genes Chromosom Cancer 13:278-284 (1995). 0 1995 Wiley-Liss. Inc.


๐Ÿ“œ SIMILAR VOLUMES


Loss of chromosome arm 8p loci in prosta
โœ Donal MacGrogan; Alina Levy; David Bostwick; Michael Wagner; Dan Wells; Robert B ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 791 KB

## Abstract A previous study of 18 primary or metastatic prostate cancers showed loss of genetic markers on chromosome 8; 10, or 16 in more than 50% of cases [Bergerheim USR et al. (1991) Genes Chromosom Cancer 3:215โ€“220]. The small size and infiltrative nature of primary prostatic tumors have hind

Identification of allelic loss on chromo
โœ Yoshiki Saitoh; Janet M. Bruner; Victor A. Levin; Athanassios P. Kyritsis ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 152 KB ๐Ÿ‘ 2 views

We employed the arbitrarily primed polymerase chain reaction (AP-PCR), which is a PCR-based genomic fingerprinting technique, to detect novel genetic alterations in human astrocytomas. DNA fingerprints generated by arbitrary primers were compared in normal lymphocytes and tumor tissues from the same